The Medical Advisor

A woman facing a lung transplant reversed her condition with a $30 over-the-counter treatment. Doctors told her she had no options. A new doctor suggested DMSO. Months later? Her lungs were CLEAR.  Erica Eyres, a vigorous fifty-six-year-old aerobics instructor who had struggled to breathe, was given “absolutely devastating” news in 2022: She might need a lung transplant. She had never smoked, ran cross-country track in high school, and was a personal trainer for years, but, by 2024, a transplant assessment was arranged. Buy on Amazon “I decided that I will make that decision,” she said, “only if it’s the last resort, and I’m on my deathbed.” A few months before her consultation, however, Eyres, then fifty-eight, made an appointment with a new primary care doctor for routine prescription refills. She was about to be introduced, literally and figuratively, to a new kind of medicine. It would change everything. Dr. James Miller, a former surgeon, liked to get to know his patients, so ...

What is DMSO? Dimethyl sulfoxide (DMSO) is a colorless, organic solvent derived from wood pulp during paper production. Discovered in the 19th century, it gained medical attention in the 1960s for its ability to rapidly penetrate skin and cell membranes, acting as an anti-inflammatory, analgesic, and tissue-protective agent.  While the FDA has approved it only for treating interstitial cystitis (a chronic bladder condition) via bladder instillation, anecdotal and clinical reports suggest broader uses for pain relief, wound healing, and more. It's often applied topically in diluted forms (e.g., 70% solution) but can cause side effects like garlic-like breath, skin irritation, or nausea at higher doses. Always consult a healthcare provider before use, as it's not regulated for most off-label applications. DMSO's history includes early promise for arthritis and injuries, halted by FDA concerns over eye toxicity in animal studies (later not replicated in humans). Despite this, ...

Introduction The potential applications of Ivermectin and Benzimidazole (Fenbendazole and Mebendazole) in cancer treatment have sparked significant interest online, with growing communities exploring these compounds for therapeutic use. While both have roots in anti-parasitic medicine, emerging research and anecdotal evidence suggest they may offer benefits in combating colorectal cancers. The main goal with this article is to provide as much clear information as possible for someone dealing with colorectal cancer. This article deals with the basis and practical approach to using Fenbendazole and Ivermectin for colorectal cancer. Can Fenbendazole and Ivermectin play a key role in treating Stage 4 Colorectal Cancer? Several peer-reviewed papers and case studies (below) strongly suggest that it might: Ivermectin, Fenbendazole and Mebendazole in Cancer: 2024 Peer-Reviewed Protocol in Cancer Ivermect...